Amended Current Report Filing (8-k/a)
17 Febbraio 2017 - 7:32PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
Fourth
Amendment
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF ORIGINAL REPORT:
JUNE
29, 2016
DATE OF FIRST AMENDMENT: AUGUST 30,
2016
DATE OF SECOND AMENDMENT: SEPTEMBER
2, 2016
DATE OF THIRD AMENDMENT: DECEMBER
14, 2016
DATE OF FOURTH AMENDMENT: FEBRUARY
17, 2017
US Nuclear Corp.
(EXACT NAME OF REGISTRANT AS SPECIFIED
IN CHARTER)
|
|
|
|
|
Delaware
|
|
000-54617
|
|
45-4535739
|
(STATE OR OTHER JURISDICTION OF
INCORPORATION OR ORGANIZATION)
|
|
(COMMISSION FILE NO.)
|
|
(IRS EMPLOYEE IDENTIFICATION NO.)
|
7051 Eton Avenue
Canoga Park, CA 91303
(ADDRESS OF PRINCIPAL
EXECUTIVE OFFICES)
(
818)
883-7043
(ISSUER TELEPHONE
NUMBER)
N/A
(FORMER NAME OR
FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General
Instruction A.2. below):
¨
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Explanatory Note:
This Form 8-K/A (Fourth Amendment) has
been submitted to disclose the extension of the private offering pursuant to resolution and consent of the Board of Directors,
and to incorporate an updated, forward-looking projections and business presentation. The private offering has also been amended
to increase the number of shares available under the offering from 2,000,000 to 7,000,000. Otherwise, the balance of the previously
disclosed offering has not been amended.
SECTION 8 – OTHER EVENTS
Item 8.01 Other Events
Private Offering of Restricted Securities Under Rule 506(b)
of Regulation D
On June 28, 2016, the Board of Directors
for US Nuclear Corp., a Delaware corporation (the “Company”), authorized a private offering of restricted shares of
its common stock to accredited investors, as defined in Rule 501(a) under the Securities Act of 1933, as amended (the “Securities
Act”), or to a limited number of sophisticated investors, as allowed for by the Securities Act. This offering is being made
in reliance on exemptions from registration pursuant to Section 4(2) of the Securities Act and Rule 506(b) of Regulation D promulgated
thereunder and applicable state securities laws. The offering is currently set to terminate by or before August 31, 2016; however,
it can be extended by the Board of Directors through a resolution. The Board of Directors proceeded to extend the offering through
May 1, 2017.
The Company is offering 7,000,000 shares
of its common stock at $0.30/per share with a minimum purchase of 35,000 shares. The Company may be required to seek additional
funding in the future through the issuance of equity or debt, either of which is likely to result in dilution to holders of the
stock sold in the offering. The Company might utilize the services of a registered representative under the rules promulgated by
the Financial Industry Regulatory Authority (“FINRA”) to sell its shares, which might result in commissions being paid,
and disclosed on Form D with the United States Securities and Exchange Commission.
The shares of common stock will be sold
pursuant to the terms of the Subscription Agreement (the “Subscription Agreement”) as described in the offering memorandum.
There is no impound requirement in this offering and, as such, any funds received from this offering may be used by the Company
at any time. The Company is currently listed on the OTC Markets Pink Sheets and OTC Bulletin Board exchange operated by FINRA under
the symbol “UCLE”. The Company is DTC eligible under the rules promulgated by the Depository Trust and Clearing Corporation,
and its transfer agent is Action Stock Transfer located at 2469 E. Fort Union Boulevard in Salt Lake City, Utah 84121 (phone number
(801) 274-1088).
The inclusion of the offering memorandum
as an exhibit hereto is not intended as a means of solicitation; rather, it is being disclosed as an event determined by the Board
of Directors to be relevant and necessary as part of its ongoing reporting obligations under the Securities Exchange Act of 1934.
The Company issued a press release regarding this offering disclosing, amongst other things, that the release is not to be construed
as a direct or indirect solicitation. The Company might elect to update this press release, and if so, an amendment to this Form
8-K/A will be disclosed.
SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01 Financial Statement and Exhibits.
(d) Exhibits:
Exhibit No.
|
Document
|
10.1
|
Amended Private Offering Memorandum
|
10.2
|
Press Release
|
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto
duly authorized.
U.S. Nuclear, Inc.
By:
/s/
Robert Goldstein
Name: Robert Goldstein
Title: Chief Executive Officer
and President
Dated: February 17, 2017
Grafico Azioni US Nuclear (PK) (USOTC:UCLE)
Storico
Da Feb 2025 a Mar 2025
Grafico Azioni US Nuclear (PK) (USOTC:UCLE)
Storico
Da Mar 2024 a Mar 2025